Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Implantable cardioverter defibrillator (ICD) market still a three-horse race

This article was originally published in Clinica

Executive Summary

The world market for implantable cardioverter defibrillators is projected by US analysts at UBS Securities to double from nearly $500 million in 1994 to over $1,000 million by 1998. Guidant, Medtronic and Ventritex will continue to compete for increased market share through technological advances. However, acceptance of new, expensive technologies could be jeopardised if they fail to demonstrate a cost benefit over cheaper antiarrhythmic drug therapy, caution the analysts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091847

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel